EVFM
Evofem Biosciences (EVFM)
$
01About Evofem Biosciences (EVFM)
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.
Details
Daily high
$0.01
Daily low
$0.01
Price at open
$0.01
52 Week High
$0.06
52 Week Low
$0.01
Market cap
988,200
Dividend yield
0.00%
Volume
131,364
Avg. volume
402,558
P/E ratio
-.01
Evofem Biosciences News
Details
Daily high
$0.01
Daily low
$0.01
Price at open
$0.01
52 Week High
$0.06
52 Week Low
$0.01
Market cap
988,200
Dividend yield
0.00%
Volume
131,364
Avg. volume
402,558
P/E ratio
-.01